Author

Talley Rw

Observed names: R W TALLEY, R W Talley

Observed institution: Wayne State University

OpenAlex ID: A5083375615

Clinical evaluation of toxic effects of cis-diamminedichloroplatinum (NSC-119875)--phase I clinical study.

1973 · R W Talley, R M O'Bryan, et al. · PubMed · 94

Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).

1970 · J K Luce, W G Thurman, et al. · PubMed · 79

Phase II evaluation of cis-dichlorodiammineplatinum(II) in advanced malignancies of the genitourinary and gynecologic organs: a Southwest Oncology Group Study.

1979 · A H Rossof, R W Talley, et al. · PubMed · 68

5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma.

1972 · E Frei, J K Luce, et al. · PubMed · 31

Critical analysis of the control of malignant effusions with radioisotopes.

1968 · R M O'Bryan, R W Talley, et al. · PubMed · 21

Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: a Southwest Oncology Group Study.

1979 · A H Rossof, C A Coltman, et al. · PubMed · 20

Phase II study of AMSA in lung cancer.

1981 · M K Samson, R J Fraile, et al. · PubMed · 19

Phase I--II study of intermittent bolus administration of DTIC and actinomycin D in metastatic malignant melanoma.

1978 · M K Samson, L H Baker, et al. · PubMed · 14

Preliminary trials with combination therapy of cyclophosphamide (NSC-26271), vincristine (NSC-67574), and 5-fluorouracil (NSC-19893).

1968 · W G Tucker, R W Talley, et al. · PubMed · 8

Pheochromocytoma: current concepts.

1967 · E L Moorhead, J R Caldwell, et al. · PubMed · 8

Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.

1982 · J D Cowan, D D Von Hoff, et al. · PubMed · 6

Porfiromycin in the management of epidermoid and transitional cell cancer: a phase II study.

1976 · F J Panettiere, R W Talley, et al. · PubMed · 5

The clinical use of fluorine18 in bone scanning.

1969 · R A Gastesi, A T Vulpetti, et al. · PubMed · 5

Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide in advanced adenocarcinoma and large cell carcinoma of the lung.

1979 · R J Fraile, M K Samson, et al. · PubMed · 4

Clinical evaluation of 1,3-bis(2-chloroethyl)-nitrosourea (BCNU; NSC-409962) with fluoxymesterone (NSC-12165) in the treatment of solid tumors.

1973 · E S Reyes, R W Talley, et al. · PubMed · 4

Guanazole (NSC-1895)--a phase I clinical study.

1975 · E M Caoili, R W Talley, et al. · PubMed · 3

Treatment of adenocarcinoma with combinations of cyclopjosphamide (NSC-26271), vincristine (NSC-67574), and 5-fluorouracil (NSC-19893).

1975 · W G Tucker, R W Talley, et al. · PubMed · 3

Clinical pharmacologic study of kethoxal bis(thiosemicarbazone) [NSC-82116] in advanced cancer.

1967 · W Regelson, J F Holland, et al. · PubMed · 3

Chemotherapy of advanced ovarian cancer.

1961 · V K VAITKEVICIUS, R W TALLEY, et al. · PubMed · 3

Phase II trial of amsacrine in metastatic or locally recurrent squamous cell carcinoma from head and neck primaries: a Southwest Oncology Group study.

1984 · R P Witherspoon, S S Legha, et al. · PubMed · 2

Response of advanced breast cancer to two dosage regiments of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).

1973 · J D Bonnet, R W Brownlee, et al. · PubMed · 2

Proceedings: Chemotherapy of soft-tissue sarcomas.

1972 · R W Talley · PubMed · 2

Investigational and practical chemotherapy of solid tumors.

1970 · R W Talley · PubMed · 2

Clinical study of 6 alpha-methyl-9 alpha-fluoro-17-acetoxy-21-deoxyprednisolone (U-17323) in human breast cancer--preliminary report.

1961 · R W TALLEY, J E KELLY, et al. · PubMed · 2

Comparison of 1 -testololactone (NSC-23759) and an estrogen-progestin combination (NSC-77622) in the treatment of metastatic breast cancer.

1970 · R W Talley, R M O'Bryan, et al. · PubMed · 1

Works count: 29

Citation count: 409

H-index: 8

I10-index: 8